Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Go back to Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
LIGAND PHARMA (NASDAQ: LGND) Delayed: 279.44 --0 (-0%)
Previous Close $279.44    52 Week High $139.79 
Open $279.44    52 Week Low $82.07 
Day High $279.44    P/E 649.86 
Day Low $279.44    EPS $0.43 
Volume 58       

XOMA (NASDAQ: XOMA) Delayed: 41.95 --0 (-0%)
Previous Close $41.95    52 Week High $7.33 
Open $41.95    52 Week Low $0.34 
Day High $41.95    P/E N/A 
Day Low $41.95    EPS $-0.73 
Volume      

(NASDAQ: XOMAO) Delayed: 25.43 --0 (-0%)
Previous Close $25.43    52 Week High
Open $25.43    52 Week Low
Day High $25.43    P/E N/A 
Day Low $25.43    EPS
Volume      

(NASDAQ: XOMAP) Delayed: 25.48 --0 (-0%)
Previous Close $25.48    52 Week High
Open $25.48    52 Week Low
Day High $25.48    P/E N/A 
Day Low $25.48    EPS
Volume 23,915